Dimerix Limited (DXB.AX)
AUD 0.43
(1.19%)
AUD 0.43
(1.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 583.47 Thousand AUD | -93.51% |
| 2023 | 8.98 Million AUD | 38.99% |
| 2022 | 6.46 Million AUD | 45.58% |
| 2021 | 4.43 Million AUD | 89.65% |
| 2020 | 2.34 Million AUD | 61.74% |
| 2019 | 1.44 Million AUD | 71.23% |
| 2018 | 845.28 Thousand AUD | 52.41% |
| 2017 | 554.61 Thousand AUD | -9.12% |
| 2016 | 610.27 Thousand AUD | 156.36% |
| 2015 | 238.05 Thousand AUD | -32.03% |
| 2014 | 350.21 Thousand AUD | 293.62% |
| 2013 | 88.97 Thousand AUD | 0.0% |
| 2012 | - AUD | -100.0% |
| 2011 | 73.06 Thousand AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 756.95 Thousand AUD | 15.39% |
| 2007 | 655.99 Thousand AUD | 116210.82% |
| 2006 | 564.00 AUD | -99.96% |
| 2005 | 1.36 Million AUD | -49.89% |
| 2004 | 2.73 Million AUD | 9.94% |
| 2003 | 2.48 Million AUD | -40.18% |
| 2002 | 4.15 Million AUD | -22.25% |
| 2001 | 5.34 Million AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| 1992 | - AUD | 0.0% |
| 1991 | - AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 407.46 Thousand AUD | -95.46% |
| 2024 Q4 | 450.41 Thousand AUD | 0.0% |
| 2024 Q2 | 133.06 Thousand AUD | 0.0% |
| 2023 FY | 8.98 Million AUD | 38.99% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | 8.98 Million AUD | 0.0% |
| 2022 Q4 | 6.46 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | 6.46 Million AUD | 45.58% |
| 2021 Q4 | 4.3 Million AUD | 0.0% |
| 2021 FY | 4.43 Million AUD | 89.65% |
| 2021 Q2 | 130.58 Thousand AUD | 0.0% |
| 2020 Q2 | 1779.00 AUD | 0.0% |
| 2020 FY | 2.34 Million AUD | 61.74% |
| 2020 Q4 | 2.33 Million AUD | 0.0% |
| 2019 Q2 | 259.53 Thousand AUD | 0.0% |
| 2019 FY | 1.44 Million AUD | 71.23% |
| 2019 Q4 | 1.18 Million AUD | 0.0% |
| 2018 FY | 845.28 Thousand AUD | 52.41% |
| 2018 Q4 | 838.94 Thousand AUD | 0.0% |
| 2018 Q2 | 6348.00 AUD | 0.0% |
| 2017 Q2 | 8351.00 AUD | 0.0% |
| 2017 Q4 | 546.26 Thousand AUD | 0.0% |
| 2017 FY | 554.61 Thousand AUD | -9.12% |
| 2016 Q4 | 582.02 Thousand AUD | 0.0% |
| 2016 FY | 610.27 Thousand AUD | 156.36% |
| 2016 Q2 | 28.24 Thousand AUD | 0.0% |
| 2015 FY | 238.05 Thousand AUD | -32.03% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q2 | 35.81 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 Q4 | 202.23 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | 350.21 Thousand AUD | 293.62% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2013 FY | 88.97 Thousand AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | -100.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q2 | - AUD | -100.0% |
| 2012 Q1 | 18.26 Thousand AUD | 0.0% |
| 2011 Q3 | 18.26 Thousand AUD | 0.0% |
| 2011 Q2 | 18.26 Thousand AUD | 0.0% |
| 2011 FY | 73.06 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q1 | 189.23 Thousand AUD | 0.0% |
| 2009 Q2 | - AUD | -100.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q1 | 163.99 Thousand AUD | 0.0% |
| 2008 Q2 | 189.23 Thousand AUD | 15.39% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 756.95 Thousand AUD | 15.39% |
| 2008 Q3 | 189.23 Thousand AUD | 0.0% |
| 2007 Q1 | 141.00 AUD | 0.0% |
| 2007 Q2 | 163.99 Thousand AUD | 116210.64% |
| 2007 Q3 | 163.99 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 655.99 Thousand AUD | 116210.82% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q2 | 141.00 AUD | -99.96% |
| 2006 Q3 | 141.00 AUD | 0.0% |
| 2006 Q1 | 342.28 Thousand AUD | 0.0% |
| 2006 FY | 564.00 AUD | -99.96% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 342.28 Thousand AUD | 0.0% |
| 2005 Q2 | 342.28 Thousand AUD | -49.38% |
| 2005 FY | 1.36 Million AUD | -49.89% |
| 2005 Q1 | 676.18 Thousand AUD | 0.0% |
| 2004 FY | 2.73 Million AUD | 9.94% |
| 2004 Q3 | 676.18 Thousand AUD | 0.0% |
| 2004 Q2 | 676.18 Thousand AUD | 8.75% |
| 2004 Q1 | 621.8 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 Q3 | 621.8 Thousand AUD | 0.0% |
| 2003 Q1 | 1.02 Million AUD | 0.0% |
| 2003 FY | 2.48 Million AUD | -40.18% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q2 | 621.8 Thousand AUD | -39.2% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 FY | 4.15 Million AUD | -22.25% |
| 2002 Q1 | 1.33 Million AUD | 0.0% |
| 2002 Q2 | 1.02 Million AUD | -23.44% |
| 2002 Q3 | 1.02 Million AUD | 0.0% |
| 2001 FY | 5.34 Million AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q2 | 1.33 Million AUD | 0.0% |
| 2001 Q3 | 1.33 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1992 FY | - AUD | 0.0% |
| 1992 Q1 | - AUD | 0.0% |
| 1992 Q2 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1991 Q3 | - AUD | 0.0% |
| 1991 Q4 | - AUD | 0.0% |
| 1991 Q1 | - AUD | 0.0% |
| 1991 Q2 | - AUD | 0.0% |
| 1991 FY | - AUD | 0.0% |
| 1990 Q2 | - AUD | 0.0% |
| 1990 Q3 | - AUD | 0.0% |
| 1990 Q4 | - AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1990 Q1 | - AUD | 0.0% |
| 1989 Q2 | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q3 | - AUD | 0.0% |
| 1989 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | 66.424% |
| Acrux Limited | 5.09 Million AUD | 88.539% |
| Actinogen Medical Limited | 9.93 Million AUD | 94.125% |
| AnteoTech Limited | 460.39 Thousand AUD | -26.734% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 77.541% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -3332.224% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 85.483% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 86.896% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -23.213% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -3084.924% |
| Biome Australia Limited | 13 Million AUD | 95.515% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 3.048% |
| BTC Health Limited | 16.36 Thousand AUD | -3466.491% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 92.176% |
| CSL Limited | 22.41 Billion AUD | 99.997% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 94.929% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.338% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 74.803% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.122% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 53.381% |
| Immuron Limited | 4.9 Million AUD | 88.099% |
| Immutep Limited | 3.5 Million AUD | 83.356% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 51.868% |
| Memphasys Limited | 60 Thousand AUD | -872.463% |
| Nanollose Limited | 12.5 Thousand AUD | -4567.451% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.748% |
| Noxopharm Limited | 2.4 Million AUD | 75.691% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 5.31 Million AUD | 89.023% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | 1.39 Million AUD | 58.149% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -786.745% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 34.598% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 84.283% |
| PYC Therapeutics Limited | 22.05 Million AUD | 97.355% |
| Race Oncology Limited | 4 Million AUD | 85.426% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -94.994% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 8.28 Million AUD | 92.961% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.883% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -283.262% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -514.498% |